Loading clinical trials...
Loading clinical trials...
The purpose of this Clinical Trial was to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide acetate 3.75mg) in patients with precocious puberty.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
NCT06129539 · Central Precocious Puberty
NCT07359092 · Central Precocious Puberty (CPP), Puberty Disorders, and more
NCT05341128 · Central Precocious Puberty
NCT05029622 · Central Precocious Puberty
NCT06720623 · Central Precocious Puberty (CPP)
Ajou University medical center
Soo-won
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions